Signaling Pathways - Histone Deacetylases (HDACs) - ALK - calcium chelator - Insulin and Insulin-like Receptors
清除全部
- A8620 AZD-34633 CitationTarget: ALK|Insulin-like growth factors (IGFs)Summary: ALK/IGF1R抑制剂
- A8547 Tubastatin A HCl1 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6(组蛋白去乙酰化酶6)抑制剂
- A8393 CH5424802中文名: 阿来替尼Target: ALKSummary: ALK的有效ATP竞争性抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8328 LDK378中文名: 色瑞替尼Target: ALKSummary: 强效的ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A4500 TCS HDAC6 20b1 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6的选择性抑制剂
- A4498 SBHA1 CitationTarget: Histone Deacetylases (HDACs)Summary: 细胞渗透性HDAC1/HDAC3抑制剂
- A4501 Tubacin3 CitationTarget: Histone Deacetylases (HDACs)Summary: HDAC6有效的、选择性、可逆的、细胞通透性的抑制剂。